{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:37:25Z","timestamp":1761237445811},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1208\/aapsj0902018","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T19:10:02Z","timestamp":1183662602000},"page":"E164-E170","source":"Crossref","is-referenced-by-count":38,"title":["Specificity and selectivity evaluations of ligand binding assay of protein therapeutics against concomitant drugs and related endogenous proteins"],"prefix":"10.1208","volume":"9","author":[{"given":"Jean","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"92164_CR1","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1158\/1078-0432.CCR-05-1325","volume":"12","author":"S Kim","year":"2006","unstructured":"Kim S, Prichard CN, Younes MN, et al. Cetuximab and irinotecan interact synergistically to inhibit the growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice.Clin Cancer Res 2006;12:600\u2013607.","journal-title":"Clin Cancer Res"},{"key":"92164_CR2","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/art.20221","volume":"50","author":"MC Genovese","year":"2004","unstructured":"Genovese MC, Cohen S, Moreland L, et al. for the 20000223 Study Group. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.Arthritis Rheum. 2004;50:1412\u20131419.","journal-title":"Arthritis Rheum"},{"key":"92164_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1349-7006.2001.tb01149.x","volume":"92","author":"M Ohta","year":"2001","unstructured":"Ohta M, Konno H, Tanaka T, et al. Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.Cancer Sci. 2001;92:688\u2013695.","journal-title":"Cancer Sci."},{"key":"92164_CR4","first-page":"S73","volume":"17","author":"C Antoni","year":"1999","unstructured":"Antoni C, Kalden JR. Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis.Clin Exp Rheumatol. 1999;17:S73-S77.","journal-title":"Clin Exp Rheumatol"},{"key":"92164_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1600-0447.2005.00675.x","volume":"112","author":"J G\u00e1ndara de la","year":"2005","unstructured":"de la G\u00e1ndara J, Rojo JE, Ros S, et al. Neuropharmacological basis of combining antidepressants.Acta Psychiatr Scand. 2005;112:11\u201336.","journal-title":"Acta Psychiatr Scand"},{"key":"92164_CR6","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/S0959-8049(01)00309-4","volume":"37","author":"CH Smorenburg","year":"2001","unstructured":"Smorenburg CH, Sparreboom A, Bontenbal M, et al. Combination chemotherapy of the taxanes and antimetabolites: its use and limitations.Eur J Cancer. 2001;37:2310\u20132323.","journal-title":"Eur J Cancer"},{"key":"92164_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1023\/A:1011923630307","volume":"68","author":"A Manni","year":"2001","unstructured":"Manni A, Trout D, Verderame MF, et al. Effect of alpha-difluoremethyl-ornithine on the expression and function of the epidermal growth factor receptor in human breast epithelial cells in culture.Breast Cancer Res Treat. 2001;68:139\u2013146.","journal-title":"Breast Cancer Res Treat"},{"key":"92164_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/01.CIR.0000048183.37648.1A","volume":"107","author":"C Heeschen","year":"2003","unstructured":"Heeschen C, Dimmeler S, Hamm CW, et al.. prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.Circulation. 2003;107:524\u2013530.","journal-title":"Circulation"},{"key":"92164_CR9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00467-004-1418-z","volume":"19","author":"I Akil","year":"2004","unstructured":"Akil I, Yuksel H, Urk V, et al. Biochemical markers of bone metabolism and calciuria with inhaled budesonide therapy.Pediatr Nephrol. 2004;19:511\u2013515.","journal-title":"Pediatr Nephrol"},{"key":"92164_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.phrs.2006.06.006","volume":"54","author":"P Vural","year":"2006","unstructured":"Vural P, Akgul C, Canbaz M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.Pharmacol Res. 2006;54:298\u2013302.","journal-title":"Pharmacol Res"},{"key":"92164_CR11","volume-title":"Guidance for the Industry; Bioanalytical Method Validation","author":"US Department of Health and Human Services","year":"2001","unstructured":"US Department of Health and Human Services.Guidance for the Industry; Bioanalytical Method Validation. Washington, DC: US Department of Health and Human Services, FDA, CDER, and CVM; 2001."},{"key":"92164_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jps.2600810324","volume":"81","author":"VP Shah","year":"1992","unstructured":"Shah VP, Midha KK, Dighe S, et al. Analytical method validation: bioavailability, bioequivalence, and pharmacokinetic studies.J Pharm Sci. 1992;81:309\u2013312.","journal-title":"J Pharm Sci"},{"key":"92164_CR13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1023\/A:1007669411738","volume":"17","author":"VP Shah","year":"2000","unstructured":"Shah VP, Midha KK, Dighe S, et al. Bioanalytical method validation\u2014a revisit with a decade of progress.Pharm Res. 2000;17:1551\u20131557.","journal-title":"Pharm Res"},{"key":"92164_CR14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/S0731-7085(99)00244-7","volume":"21","author":"JWA Findlay","year":"2000","unstructured":"Findlay JWA, Smith WC, Lee JW, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.J Pharm Biomed Anal. 2000;21:1249\u20131273.","journal-title":"J Pharm Biomed Anal"},{"key":"92164_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1023\/A:1013062600566","volume":"18","author":"K Miller","year":"2001","unstructured":"Miller K, Bowsher RR, Celniker A, et al. Workshop on bioanalytical methods validation for macromolecules: summary report.Pharm Res. 2001;18:1373\u20131383.","journal-title":"Pharm Res"},{"key":"92164_CR16","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1023\/B:PHAM.0000003390.51761.3d","volume":"20","author":"B DeSilva","year":"2003","unstructured":"DeSilva B, Smith W, Weiner R, et al. Recommendations for the bioanalytical method validation of ligand binding assays to support pharmacokinetic assessments of macromolecules.Pharm Res. 2003;20:1885\u20131900.","journal-title":"Pharm Res"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/aapsj0902018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/aapsj0902018\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/aapsj0902018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/aapsj0902018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:41:54Z","timestamp":1559619714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/aapsj0902018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["92164"],"URL":"https:\/\/doi.org\/10.1208\/aapsj0902018","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}